journal article·2024-12-04

Modular Synthetic Platform to Tailor Therapeutic-Specific Delivery in Injectable Hydrogels

Joey Hui Min Wong, Belynn Sim, Cally Owh, Valerie Ow, Vincent Ting An Teo, Elson Wei Long Ng, Yi Jian Boo, Qianyu Lin, Jason Y. C. Lim, Xian Jun Loh, Rubayn Goh

ACS Applied Materials & Interfaces· Volume 16· Issue 48
Publisher page

Abstract

Injectable thermoresponsive hydrogels (thermogels), valued for their conformability and minimal invasiveness, are increasingly used as in situ forming implants for drug delivery and as regenerative scaffolds. These gels exhibit sol-to-gel phase transitions at body temperature. As localized depots and scaffolds, these gels determine the chemical and mechanical environments and could dramatically influence the release kinetics of drugs or the fate of cells. Current synthetic approaches for thermogels, however, often limit the ability to fully exploit interactions between the thermogel matrix and the encapsulated agent. In this study, we introduce a modular synthetic platform for creating a library of functionalized polyurethane thermogels that enables customization of gelation properties and intermolecular interactions. These thermogels can exhibit a wide range of stiffness, offer complementary ionic interactions, and enhance hydrophobic interactions and hydrogen bonding. By leveraging these tunable interactions between the thermogelling scaffold, functional groups, and encapsulated agents, we achieved sustained and controlled release, from days to over 6 months, for both low and high molecular weight drug analogs. Release profiles varied from monophasic to biphasic and triphasic depending on the compatibility between the thermogel properties and the encapsulated agents. The design rules identified here support the development of drug-specific formulations, facilitating precise, sustained, and modulated release tailored to therapeutic needs. Beyond providing an adaptable strategy for customizable injectable drug depots, this synthetic strategy lays the groundwork for future iterations of multi stimuli-responsive thermogels with enhanced bioactivity, advancing the potential for customizable, biointeractive therapeutic systems.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Hydrogels: synthesis, properties, applications · Advanced Materials and Mechanics · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, #08-03 Innovis, Singapore 138634, Republic of Singapore

School of Materials Science and Engineering, Nanyang Technological University (NTU), Singapore 639798, Republic of Singapore

Department of Biomedical Engineering, National University of Singapore (NUS), 4 Engineering Drive 3, Singapore 117583, Singapore

Department of Materials Science and Engineering, National University of Singapore (NUS), 9 Engineering Drive, Singapore 117576, Singapore

Funding

Agency for Science, Technology and Research · National Research Foundation Singapore

References (86)

Show source-provided references
1. 10.1016/j.carbpol.2018.03.03110.1016/j.carbpol.2018.03.031 ↗
2. 10.1038/natrevmats.2016.7110.1038/natrevmats.2016.71 ↗
3. 10.1039/D3LP00136A10.1039/D3LP00136A ↗
4. 10.1038/s41467-022-32804-010.1038/s41467-022-32804-0 ↗
5. 10.1016/j.addr.2018.03.00710.1016/j.addr.2018.03.007 ↗
6. 10.1016/j.actbio.2021.09.03410.1016/j.actbio.2021.09.034 ↗
7. 10.1016/j.biomaterials.2020.12054710.1016/j.biomaterials.2020.120547 ↗
8. 10.1016/j.biomaterials.2014.03.04510.1016/j.biomaterials.2014.03.045 ↗
9. 10.1039/D0TB01074J10.1039/D0TB01074J ↗
10. 10.1021/bm060793310.1021/bm0607933 ↗
11. 10.1016/j.mtadv.2019.10002110.1016/j.mtadv.2019.100021 ↗
12. 10.1016/j.jconrel.2014.04.05610.1016/j.jconrel.2014.04.056 ↗
13. 10.1021/accountsmr.1c0012810.1021/accountsmr.1c00128 ↗
14. 10.1021/acs.biomac.4c0069010.1021/acs.biomac.4c00690 ↗
15. 10.1038/nmat448910.1038/nmat4489 ↗
16. 10.1039/C0SM00611D10.1039/C0SM00611D ↗
17. 10.1016/j.biomaterials.2008.04.02510.1016/j.biomaterials.2008.04.025 ↗
18. 10.1021/acsbiomaterials.2c0097910.1021/acsbiomaterials.2c00979 ↗
19. 10.1016/j.cej.2020.12687910.1016/j.cej.2020.126879 ↗
20. 10.1021/bm300103u10.1021/bm300103u ↗
21. 10.1002/asia.20220062110.1002/asia.202200621 ↗
22. 10.1016/j.carbpol.2022.11955910.1016/j.carbpol.2022.119559 ↗
23. 10.1016/j.jconrel.2020.12.03710.1016/j.jconrel.2020.12.037 ↗
24. 10.1039/C4TB02033B10.1039/C4TB02033B ↗
25. 10.1002/anie.20090392410.1002/anie.200903924 ↗
26. 10.1016/j.addr.2006.09.00410.1016/j.addr.2006.09.004 ↗
27. 10.1002/marc.20180011710.1002/marc.201800117 ↗
28. 10.1002/adhm.20177005310.1002/adhm.201770053 ↗
29. 10.1097/00000542-200505000-0002210.1097/00000542-200505000-00022 ↗
30. 10.1111/j.1365-2265.2009.03744.x10.1111/j.1365-2265.2009.03744.x ↗
31. 10.1021/acsami.6b0467910.1021/acsami.6b04679 ↗
32. 10.1016/j.msec.2021.11255610.1016/j.msec.2021.112556 ↗
33. 10.1021/acsami.8b0141010.1021/acsami.8b01410 ↗
34. 10.1016/j.actbio.2021.04.00910.1016/j.actbio.2021.04.009 ↗
35. 10.1021/ma990899910.1021/ma9908999 ↗
36. 10.1021/acsbiomaterials.5b0051510.1021/acsbiomaterials.5b00515 ↗
37. 10.1016/j.mtchem.2021.10067410.1016/j.mtchem.2021.100674 ↗
38. 10.1002/anie.20050357510.1002/anie.200503575 ↗
39. 10.1039/C9MH01822K10.1039/C9MH01822K ↗
40. 10.1016/j.actbio.2020.04.05510.1016/j.actbio.2020.04.055 ↗
41. 10.1016/j.addr.2021.02.00210.1016/j.addr.2021.02.002 ↗
42. 10.1111/j.1524-4725.2010.01743.x10.1111/j.1524-4725.2010.01743.x ↗
43. Bruschi M. L. · 2015 · 63
44. Singhvi G. · Int. J. Pharm. Stud. Res. · 2011 · 2 · 77
45. 10.3389/fphar.2022.86506510.3389/fphar.2022.865065 ↗
46. 10.2147/DDDT.S10791710.2147/DDDT.S107917 ↗
47. 10.3390/pharmaceutics1406118810.3390/pharmaceutics14061188 ↗
48. 10.1016/j.solener.2022.02.00310.1016/j.solener.2022.02.003 ↗
49. 10.1016/j.eti.2020.10087210.1016/j.eti.2020.100872 ↗
50. 10.1016/S0032-3861(03)00370-710.1016/S0032-3861(03)00370-7 ↗
51. 10.1021/acs.molpharmaceut.5b0072510.1021/acs.molpharmaceut.5b00725 ↗
52. 10.1021/ar800001k10.1021/ar800001k ↗
53. Friebolin H. · 2005 · 7
54. 10.1039/C9CS00285E10.1039/C9CS00285E ↗
55. 10.1021/jp030316410.1021/jp0303164 ↗
56. 10.1016/0005-2736(85)90381-510.1016/0005-2736(85)90381-5 ↗
57. 10.1002/pi.135710.1002/pi.1357 ↗
58. Israelachvili J. N. · 2011
59. 10.1016/j.carbpol.2022.12030810.1016/j.carbpol.2022.120308 ↗
60. 10.1021/acs.biomac.0c0007710.1021/acs.biomac.0c00077 ↗
61. 10.1080/10717544.2018.145576310.1080/10717544.2018.1455763 ↗
62. 10.1039/C2AY26101D10.1039/C2AY26101D ↗
63. 10.1088/1742-6596/1999/1/01201510.1088/1742-6596/1999/1/012015 ↗
64. 10.1016/j.fluid.2012.06.01910.1016/j.fluid.2012.06.019 ↗
65. 10.1016/j.cplett.2016.10.02710.1016/j.cplett.2016.10.027 ↗
66. 10.1021/ma301848710.1021/ma3018487 ↗
67. 10.1016/S0168-3659(99)00194-710.1016/S0168-3659(99)00194-7 ↗
68. 10.1016/j.ijpharm.2005.01.01710.1016/j.ijpharm.2005.01.017 ↗
69. 10.1021/acsbiomaterials.0c0122810.1021/acsbiomaterials.0c01228 ↗
70. 10.1016/j.ijpharm.2019.11881910.1016/j.ijpharm.2019.118819 ↗
71. 10.1021/acs.biomac.9b0061810.1021/acs.biomac.9b00618 ↗
72. 10.1021/acs.molpharmaceut.5b0016210.1021/acs.molpharmaceut.5b00162 ↗
73. 10.1039/C3SM52285G10.1039/C3SM52285G ↗
74. 10.1016/j.ejps.2020.10568910.1016/j.ejps.2020.105689 ↗
75. 10.1016/j.ijbiomac.2020.11.12610.1016/j.ijbiomac.2020.11.126 ↗
76. 10.1016/j.msec.2018.10.04810.1016/j.msec.2018.10.048 ↗
78. 10.1039/C2PY20889J10.1039/C2PY20889J ↗
79. 10.1016/j.jconrel.2017.03.00310.1016/j.jconrel.2017.03.003 ↗
80. 10.1039/C9BM01049A10.1039/C9BM01049A ↗
81. 10.5863/1551-6776-21.3.19210.5863/1551-6776-21.3.192 ↗
82. 10.1016/j.ajps.2024.10088710.1016/j.ajps.2024.100887 ↗
83. 10.1021/acs.molpharmaceut.2c0088210.1021/acs.molpharmaceut.2c00882 ↗
84. 10.3389/fphar.2018.0146110.3389/fphar.2018.01461 ↗
85. 10.3389/fphar.2022.102256710.3389/fphar.2022.1022567 ↗
86. 10.1021/acsnano.4c0559810.1021/acsnano.4c05598 ↗